News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Community Health Workers Boost BP Control in South Asian Immigrants Todd Neale February 24, 2023
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Conference News AHA 2022 Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering Caitlin E. Cox November 08, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Daily News Cardio-Obstetrics Merits Better Training, Wider Uptake: Survey Caitlin E. Cox April 26, 2022
News Daily News Segregation Linked to Hypertension Among Black, Hispanic Individuals Caitlin E. Cox February 01, 2022
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Features Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks? L.A. McKeown February 26, 2018
News Daily News Patients in PCI Trials Vary Around the World, With Women Still Underrepresented Michael O'Riordan September 15, 2017